P. Chollet

Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer

Sylvie Giacchetti, B Perpoint, Rachid Zidani et al. · Journal of Clinical Oncology · 2000 · 1.4K citations

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Javier Cortés, Joyce O’Shaughnessy, David Loesch et al. · The Lancet · 2011 · 1.1K citations

Metastatic Breast Cancer, Oncology, Breast Oncology +8

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

D. Machover, Emma Goldschmidt, P. Chollet et al. · Journal of Clinical Oncology · 1986 · 397 citations

Gastric Adenocarcinomas, Expanded Trial, Surgical Oncology +15

Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial

Françis Lévi, Rachid Zidani, Jean-Michel Vannetzel et al. · JNCI Journal of the National Cancer Institute · 1994 · 389 citations

Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

Mathilde Bayet‐Robert, Fabrice Kwiatowski, Marianne Leheurteur et al. · Cancer Biology & Therapy · 2010 · 386 citations · Full text